MedPath

An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers

Not Applicable
Completed
Conditions
Smoking
Tobacco Use
Tobacco Dependence
Tobacco Use Disorder
Tobacco Use Cessation
Smoking, Tobacco
Tobacco Smoking
Smoking Cessation
Smoking, Cigarette
Registration Number
NCT03553992
Lead Sponsor
University of California, San Francisco
Brief Summary

The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexual or gender minorities (SGM), and use Facebook. Primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 months.

Detailed Description

Participants will be randomized to one of two conditions: (1) a 6-month Facebook-delivered intervention addressing tobacco use, tailored to SGM young adults; or (2) a 6-month Facebook intervention targeting tobacco use. Both interventions will include 180 days of Facebook-based messages and activities tailored to participants' readiness to quit smoking.

Assessments will occur at baseline, 3, and 6 months follow-up. Assessments will include measures on smoking, thoughts about abstinence, and SGM identity experiences. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva nicotine test kits that will be mailed to participants.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
173
Inclusion Criteria
  • read English
  • between 18 and 25 years of age
  • indicate they use Facebook "most" (≥ 4) days per week
  • have smoked ≥100 cigarettes in their lives and currently smoke at least 1 cigarette per day on 4 or more days of the week
  • identifies as SGM
  • lives in California
Read More
Exclusion Criteria
  • do not read English
  • are not between 18 and 25 years of age
  • indicate they do not use Facebook "most" (≥ 4) days per week
  • have not smoked ≥100 cigarettes in their lives and currently smoke at least 1 cigarette per day on 4 or more days of the week
  • does not identify as SGM
  • does not live in California
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
7-day point prevalence abstinence at 6 months6 months post baseline

Reports of no smoking in the 7 days prior to the 6 month assessment. Biochemical verification of abstinence will also be recorded.

7-day point prevalence abstinence at 3 months3 months post baseline

Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded.

Secondary Outcome Measures
NameTimeMethod
Reduction in cigarettes smoked by at least 50%3 and 6 months post baseline

Reduction will be assessed at 3 and 6 month follow-ups

Tobacco use quit attempts3 and 6 months post baseline

A Smoking Questionnaire will assess the presence and number of 24 hr quit attempts since the last assessment, used to calculate presence of at least one quit attempt (y/n) in the assessment time period. This questionnaire has good internal consistency and construct validity, and is routinely used in smoking treatment research.

Readiness to quit tobacco3 and 6 months post baseline

Proportion of participants ready to quit smoking in the next month assessed at 3 and 6 months.

Thoughts About Tobacco Abstinence3 and 6 months post baseline

The 4-item Thoughts About Abstinence Form, will measure thoughts about abstinence (desire to quit, abstinence self-efficacy, and perceived difficulty of quitting) on a scale from 1 ("least") to 10("most"), and abstinence goal as no goal, intermediary goal (e.g., reduced smoking), or total abstinence.

Trial Locations

Locations (1)

University of California San Francisco Department of Psychiatry

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath